News & Analysis on Clinical Trial Services & Contract Research And Development
PEOPLE ON THE MOVE
Rentschler Biopharma SE
By Melissa Fassbender
- Last updated on
The Germany-based CDMO has appointed Dr. Ralf Otto as COO, succeeding Thomas Siklosi who will move to the Dr. Rentschler Holding GmbH & Co. KG.
In his new role, Otto will be responsible for development, manufacturing, and quality management.
Otto was most recently a partner at McKinsey & Company and has led consulting projects for large, medium, and small biopharmaceutical companies.
He has also held executive positions in cell biology and biopharmaceutical manufacturing at Boehringer Ingelheim
"With the outstanding experience of our employees, providing many years of know-how, a strong commitment to values and quality, Rentschler Biopharma will continue to strengthen its position in the growing biopharmaceutical market and respond to the demanding regulatory requirements and the increasing needs of our international clients," said Otto.